About Dual AAV
Dual AAV vectors split your gene into two vectors that under in-vivo homologous recombination, reforms to produce a full gene product. These are used when payloads >4.7kb are required.
Dual AAV vector controls contain two AAV vectors, with each vector carrying half of a GFP reporter gene. When recombined, a functional GFP is formed, allowing quick visual read-out.
Your team can use dual AAV vector controls to de-risk projects, for proof-of-principle studies, and to optimize parameters before moving into larger, more complex experiments. These controls are available in a wide range of promoters for tissue targeting.
Features
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
AAV-h-ARHGAP26-shRNA
Cat No: shAAV-201324
Availability: 6-8 weeks
AAV-h-ARHGAP27-shRNA
Cat No: shAAV-201327
Availability: 6-8 weeks
AAV-h-ARHGAP28-shRNA
Cat No: shAAV-201329
Availability: 6-8 weeks
AAV-h-ARHGAP29-shRNA
Cat No: shAAV-201330
Availability: 6-8 weeks
AAV-h-ARHGAP30-shRNA
Cat No: shAAV-201332
Availability: 6-8 weeks
AAV-h-ARHGAP4-shRNA
Cat No: shAAV-201333
Availability: 6-8 weeks
AAV-h-ARHGAP5-shRNA
Cat No: shAAV-201334
Availability: 4-5 weeks
AAV-h-ARHGAP6-shRNA
Cat No: shAAV-201335
Availability: 6-8 weeks
AAV-h-PRR5-shRNA
Cat No: shAAV-201336
Availability: 4-5 weeks
AAV-h-ARHGAP9-shRNA
Cat No: shAAV-201337
Availability: 4-5 weeks
AAV-h-ARHGDIA-shRNA
Cat No: shAAV-201338
Availability: 4-5 weeks
AAV-h-ARHGDIB-shRNA
Cat No: shAAV-201348
Availability: 4-5 weeks
